In this podcast, Bruce Rollman, MD, from the University of Pittsburgh, discusses the preliminary results of his Hopeful Heart Trial, a study in which enrolled depressed and non-depressed patients with heart...
The co-chairs of the writing committee for the “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease” answer our questions about the updated guideline and why aspirin is no longer...
He discusses his research on scaling up pharmacist-led blood pressure control programs in black barbershops, how these programs would affect long-term population health and cost of health care, and more. ...
In this video, Keith C. Ferdinand, MD, from Tulane University, discusses how community-based hypertension control programs can be successfully implemented into barbershops and other community centers.
In this commentary, a team from Johns Hopkins Medicine writes about their experiences creating and implementing a digital health platform and explains how apps can contribute to improving patients’ health.
...
She talks about her research that examined the relative strength of associations between region, hospital, and patient characteristics with high-intensity statin use after myocardial...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
In this video, James Matera, MD, talks about the critical questions patients have about CKD, the impact of CKD on comorbid conditions and the need to limit risk, and more.
James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
